US Bancorp’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$568K Sell
6,840
-9,715
-59% -$527K ﹤0.01% 1494
2026
Q1
$638K Buy
16,555
+1,970
+14% +$81.9K ﹤0.01% 1371
2025
Q4
$677K Buy
14,585
+11,475
+369% +$553K ﹤0.01% 1372
2025
Q3
$153K Buy
3,110
+1,524
+96% +$79.7K ﹤0.01% 2141
2025
Q2
$82.1K Buy
+1,586
New +$64.1K ﹤0.01% 2532

Other funds holding HNGE

US Bancorp's HNGE Position: Q2 2026 in Review

US Bancorp reduced its Hinge Health (HNGE) stake by 59% in Q2 2026, selling an estimated $527K and leaving 6,840 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #1494.

US Bancorp first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $677K in Q4 2025. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • US Bancorp held 6,840 shares of Hinge Health worth $568K as of Q2 2026.
  • US Bancorp sold 9,715 Hinge Health shares in Q2 2026, an estimated $527K.
  • Hinge Health made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1494 holding.
  • US Bancorp first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • US Bancorp's Hinge Health position peaked at $677K in Q4 2025.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.